GX 623 (Ziagen 300 mg)
Generic Name: abacavir
Pill imprint GX 623 has been identified as Ziagen 300 mg.
Ziagen is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Ziagen 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- GX 623
- 300 mg
- 18.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
sodium starch glycolate type A potato
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-4883||A-S Medication Solutions, LLC (repackager)|
|54868-4522||Physicians Total Care Inc (repackager)|
|35356-0075||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Ziagen (abacavir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.